Codexis, Inc. (CDXS) by event type
CDXS moves most on analyst upgrades — a median of -1.26% at 30 minutes across 12 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the CDXS overview →
How CDXS reacts across 3 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,647 of 2,717 | 12 | -1.26% | 17% | +0.44% |
| Analyst downgrades 447 of 2,603 | 12 | +0.44% | 58% | +2.96% |
| Rating reiterations 2,985 of 3,522 | 19 | -0.23% | 32% | 0.00% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how CDXS usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · CDXS overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | 269 | -0.01% | 46% |
| CONMED Corporation (CNMD) | 268 | -0.11% | 47% |
| CytomX Therapeutics, Inc. (CTMX) | 267 | 0.00% | 44% |
| Galapagos NV - American Depositary Shares (GLPG) | 267 | -0.05% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.